About this document
Drug Repurposing Against Staphylococcus aureus by haniumair is a document available to read on EtoBox.
Staphylococcus aureus remains a significant public health threat due to its drug resistance, prompting a search for new antimicrobial agents. This review discusses the potential of drug repurposing, highlighting several FDA-approved drugs that exhibit antimicrobial activity against S. aureus, including ebselen, ivacaftor, celastrol, and auranofin. The findings suggest that repurposed drugs could enhance the current antimicrobial pipeline and address the challenges posed by resistant strains of this pathogen
- Author
- haniumair
- Language
- EN